Drug comparisons
Galcanezumab vs Diflunisal
Galcanezumab is a monoclonal antibody blocking CGRP for migraine prevention, while Diflunisal is an NSAID with black box warning for pain and inflammation. Selection depends on specific medical needs and should be determined by a healthcare provider.
No comparison dimensions are available for this page.
Clinical context
Individuals with chronic migraines may compare Galcanezumab, a CGRP inhibitor, to Diflunisal, an NSAID, for pain management options.
Bottom line
Both Galcanezumab and Diflunisal are effective in their respective roles for pain and migraine management but should be used only as prescribed by a healthcare professional.
All medication comparisons